These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17266597)

  • 1. Discovery of inhibitors of protein-protein interactions from combinatorial libraries.
    Vicent MJ; Pérez-Payá E; Orzáez M
    Curr Top Med Chem; 2007; 7(1):83-95. PubMed ID: 17266597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic combinatorial chemistry: a tool to facilitate the identification of inhibitors for protein targets.
    Mondal M; Hirsch AK
    Chem Soc Rev; 2015 Apr; 44(8):2455-88. PubMed ID: 25706945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide arrays and peptide combinatorial libraries for the exploration of protein-ligand interactions and the design of protein inhibitors.
    Eichler J
    Comb Chem High Throughput Screen; 2005 Mar; 8(2):135-43. PubMed ID: 15777177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis.
    Bhattacharyya S
    Curr Med Chem; 2001 Oct; 8(12):1383-404. PubMed ID: 11562273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery.
    Huang R; Leung IK
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational identification of inhibitors of protein-protein interactions.
    Zhong S; Macias AT; MacKerell AD
    Curr Top Med Chem; 2007; 7(1):63-82. PubMed ID: 17266596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Object-oriented approach to drug design enabled by NMR SOLVE: first real-time structural tool for characterizing protein-ligand interactions.
    Sem DS; Yu L; Coutts SM; Jack R
    J Cell Biochem Suppl; 2001; Suppl 37():99-105. PubMed ID: 11842434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions.
    Boger DL; Desharnais J; Capps K
    Angew Chem Int Ed Engl; 2003 Sep; 42(35):4138-76. PubMed ID: 14502729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.
    Liebeschuetz JW; Jones SD; Morgan PJ; Murray CW; Rimmer AD; Roscoe JM; Waszkowycz B; Welsh PM; Wylie WA; Young SC; Martin H; Mahler J; Brady L; Wilkinson K
    J Med Chem; 2002 Mar; 45(6):1221-32. PubMed ID: 11881991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of combinatorial chemistry on drug discovery.
    Lee A; Breitenbucher JG
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):494-508. PubMed ID: 12951813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial chemistry in cancer drug development.
    Leonard KA; Deisseroth AB; Austin DJ
    Cancer J; 2001; 7(1):79-83. PubMed ID: 11269651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of combinatorial chemistry.
    Crooks SL; Charles LJ
    Curr Protoc Pharmacol; 2001 May; Chapter 9():Unit 9.3. PubMed ID: 22293968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of combinatorial and parallel synthesis chemistry methodologies to antiparasitic drug discovery.
    Musonda CC; Chibale K
    Curr Med Chem; 2004 Oct; 11(19):2519-33. PubMed ID: 15544460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational protein design: structure, function and combinatorial diversity.
    Kang SG; Saven JG
    Curr Opin Chem Biol; 2007 Jun; 11(3):329-34. PubMed ID: 17524729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo proteins from combinatorial libraries.
    Moffet DA; Hecht MH
    Chem Rev; 2001 Oct; 101(10):3191-203. PubMed ID: 11710068
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-directed combinatorial library design.
    Zhou JZ
    Curr Opin Chem Biol; 2008 Jun; 12(3):379-85. PubMed ID: 18328830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA fragmentation-based combinatorial approaches to soluble protein expression Part I. Generating DNA fragment libraries.
    Prodromou C; Savva R; Driscoll PC
    Drug Discov Today; 2007 Nov; 12(21-22):931-8. PubMed ID: 17993411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.